Pregnancy and Childbirth
Conditions
Interventions
Routine PPH prevention and treatment care
Package of intervention without HSC or TXA
Package of intervention with HSC but without TXA
Package of intervention with HSC and TXA
Sponsors
UNFPA Humanitarian Division
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: A woman will be eligible to participate in the study after she has (1) given birth at the facility and (2) provided informed consent (which will be done during the postpartum period before her discharge from the facility). Adult participants will give their informed consent. Non-adult participants will give their informed assent and their respective parents or guardians their informed consent.
Exclusion criteria
Exclusion criteria: (1) has not given birth at the facility (2) has not provided informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) proportion of birthing women receiving a uterotonic for PPH prevention. This overall proportion will be broken down by type of uterotonics that are available (e.g., oxytocin, misoprostol) or will be made available (HSC) in facilities; ;(2) proportion of women with clinical PPH receiving a uterotonic for PPH treatment (e.g., oxytocin, misoprostol); | — |
Secondary
| Measure | Time frame |
|---|---|
| (3) proportion of women with clinical PPH receiving TXA for PPH treatment. | — |
Countries
Sudan, Uganda
Contacts
Public ContactCatrin;Raphael Okpwoku Schulte Hillen;sukere
Technical Advisor;UNFPA study coordinator
Outcome results
None listed